Caffeine modulates glucocorticoid-induced expression of CTGF in lung epithelial cells and fibroblasts.

ABSTRACT:

Background

Although caffeine and glucocorticoids are frequently used to treat chronic lung disease in preterm neonates, potential interactions are largely unknown. While anti-inflammatory effects of glucocorticoids are well defined, their impact on airway remodeling is less characterized. Caffeine has been ascribed to positive effects on airway inflammation as well as remodeling. Connective tissue growth factor (CTGF, CCN2) plays a key role in airway remodeling and has been implicated in the pathogenesis of chronic lung diseases such as bronchopulmonary dysplasia (BPD) in preterm infants. The current study addressed the impact of glucocorticoids on the regulation of CTGF in the presence of caffeine using human lung epithelial and fibroblast cells.

Methods

The human airway ep

SUBMITTER: Fehrholz M 

PROVIDER: S-EPMC5363056 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature